LOADING
Comparing Mastercard Inc (MA) and Merck & Company (MRK) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | MRK |
|---|---|---|
| Price | $488.07 | $119.60 |
| Change Today | +0.82% | +3.57% |
| Market Cap | $427.7B | $285.2B |
| P/E Ratio | 28.0 | 32.5 |
| Forward P/E | 24.7 | 22.8 |
| PEG Ratio | 1.49 | 5.37 |
| EPS | $17.28 | $3.55 |
| Revenue Growth (YoY) | 15.8% | 4.9% |
| Profit Margin | 45.9% | 13.6% |
| Return on Equity | 232.1% | 18.9% |
| Dividend Yield | 0.67% | 2.88% |
| Beta | 0.74 | 0.22 |
| 52-Week High | $599.05 | $123.33 |
| 52-Week Low | $464.52 | $74.18 |
| Volume | 3.9M | 10.5M |
Mastercard Inc is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.